Wilson's Disease and Cardiac Myopathy

Area of Science:

• Cardiology
• Genetics
• Internal Medicine

Background:

• Wilson's disease is a genetic disorder characterized by excessive copper accumulation, primarily affecting the liver and brain.
• The cardiac implications of Wilson's disease, particularly concerning heart failure and atrial fibrillation, remain incompletely understood.
• Existing data on copper deposition in the heart and associated cardiovascular risks are conflicting.

Purpose of the Study:

• To investigate the association between Wilson's disease and the risk of developing cardiac myopathy.
• To determine if Wilson's disease increases the incidence of atrial fibrillation (AF) and heart failure (HF).
• To underscore the importance of cardiac surveillance in patients diagnosed with Wilson's disease.

Main Methods:

• A longitudinal study analyzing 14.3 million patient records from the California Healthcare Cost and Utilization Project database (2005-2009).
• International Classification of Diseases-9th Edition codes were used to identify patients with Wilson's disease, AF, HF, and relevant covariates.
• Validation cohorts for cirrhosis and appendicitis diagnoses were included to confirm cohort accuracy.

Main Results:

• The study identified 463 patients with Wilson's disease.
• Patients with Wilson's disease showed a significantly higher risk of cirrhosis (HR 2.85) and no increased risk of appendicitis (HR 0.24).
• Wilson's disease was associated with a 29% increased risk of AF (HR 1.29) and a 55% increased risk of HF (HR 1.55) after adjusting for multiple covariates.

Conclusions:

• Wilson's disease is linked to a significantly elevated risk of both atrial fibrillation and heart failure.
• These findings emphasize the necessity of proactive cardiac monitoring and evaluation in individuals with Wilson's disease.
• Further research into the role of copper metabolism in the pathogenesis of heart disease is warranted.